Genetic Causes of Sudden Cardiac Arrest in the Community
Preprint
Abstract
Background: Annually 300,000 Americans experience sudden cardiac arrest (SCA). Studies in referral SCA cohorts have observed rare variants in genes associated with arrhythmia and cardiomyopathy. We sought to: (1) establish the population prevalence of rare disease-causing variants in a set of candidate genes and (2) confirm the association of disease-causing variants in these genes with SCA in two prospective population-based studies. Methods: SCA patients (n=3264) were accrued from the Oregon Sudden Unexpected Death Study and the PREdiction of Sudden death in mulTi-ethnic cOmmunities (PRESTO) study and compared to control patients (n=13713) from the Atherosclerosis Risk in Communities (ARIC) study. Whole genome sequencing was performed. Disease-causing (likely pathogenic or pathogenic) variants in candidate genes associated with arrhythmia/cardiomyopathy were identified using updated American College of Medical Genetics and Genomics criteria. Gene- collapsing case-control analysis was performed using the conditional logistic regression-sequence kernel association test. Results: We identified 300 disease-causing variants, the majority of which were in cardiomyopathy genes (71%). There were 136 patients (4.2%) in the SCA group and 351 patients (2.6%) in the control group with one or more disease-causing variants (OR 1.66, 95% confidence interval 1.33-2.07, pBAG3, DSC2, DSG2, FLNC, LMNA, MYBPC3, TNNI3, TNNT2, TTN ) and four with arrhythmia ( CACNA1C, CASQ2, KCNH2, KCNQ1 ). Conclusions: Disease-causing variants in cardiomyopathy genes were the predominant genetic cause of SCA. These findings inform which genes to include in genetic screening for SCA.Keywords
This publication has 38 references indexed in Scilit:
- Concealed Cardiomyopathy in Autopsy-Inconclusive Cases of Sudden Cardiac Death and Implications for FamiliesJACC, 2022
- Prognostic Prediction of Genotype vs Phenotype in Genetic CardiomyopathiesJACC, 2022
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart FailureJACC, 2022
- Genetic Variants Associated With Unexplained Sudden Cardiac Death in Adult White and African American IndividualsJAMA Cardiology, 2021
- The ARIC (Atherosclerosis Risk In Communities) StudyJACC, 2021
- Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelinesHuman Mutation, 2020
- Rare Genetic Variants Associated With Sudden Cardiac Death in AdultsJACC, 2019
- Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterionHuman Mutation, 2018
- Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic DysfunctionJACC, 2006
- Current burden of sudden cardiac death: Multiple source surveillance versus retrospective death certificate-based review in a large U.S. communityJACC, 2004